Condition: Primary Biliary Cholangitis · Sponsor: Gilead Sciences
To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.
This description comes directly from the study's public registry record.
Gilead Clinical Study Information Center · 1-833-445-3230 (GILEAD-0) · GileadClinicalTrials@gilead.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| St. Joseph's Hospital and Medical Center - 350 W. Thomas | Phoenix, Arizona, United States | Recruiting |
| OM Research LLC | Lancaster, California, United States | Recruiting |
| SCPMG/Kaiser Permanente Los Angeles Medical Center | Los Angeles, California, United States | Recruiting |
| Cedar Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| California Liver Research Institute | Pasadena, California, United States | Recruiting |
| Stanford University | Redwood City, California, United States | Recruiting |
| University of California, Davis Medical Center | Sacramento, California, United States | Recruiting |
| California Pacific Medical Center - Sutter Pacific Medical Foundation | San Francisco, California, United States | Recruiting |
| Connie Frank Transplant Center at UCSF | San Francisco, California, United States | Recruiting |
| Kaiser Permanente - South San Francisco Medical Center | South San Francisco, California, United States | Recruiting |
| Covenant Metabolic Specialists, LLC | Fort Myers, Florida, United States | Recruiting |
+ 193 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06051617